These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27378567)

  • 21. Augmentation of cGMP/PKG pathway and colonic motility by hydrogen sulfide.
    Nalli AD; Bhattacharya S; Wang H; Kendig DM; Grider JR; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2017 Oct; 313(4):G330-G341. PubMed ID: 28705807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies.
    Sharina IG; Sobolevsky M; Papakyriakou A; Rukoyatkina N; Spyroulias GA; Gambaryan S; Martin E
    Br J Pharmacol; 2015 May; 172(9):2316-29. PubMed ID: 25536881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation.
    Jones AW; Durante W; Korthuis RJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):85-91. PubMed ID: 20605906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronological Change of Vascular Reactivity to cGMP Generators in the Balloon-Injured Rat Carotid Artery.
    Tawa M; Shimosato T; Sakonjo H; Masuoka T; Nishio M; Ishibashi T; Okamura T
    J Vasc Res; 2019; 56(3):109-116. PubMed ID: 31085923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing the soluble guanylate cyclase heme redox state in blood vessels.
    Tawa M; Okamura T
    Vascul Pharmacol; 2022 Aug; 145():107023. PubMed ID: 35718342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
    Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ
    J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation.
    Lin Y; Chen Y; Zhu N; Zhao S; Fan J; Liu E
    Biomed Pharmacother; 2016 Oct; 83():466-476. PubMed ID: 27427853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrogen sulfide donor, NaHS, stimulates ANP secretion via the K
    Yu L; Park BM; Ahn YJ; Lee GJ; Kim SH
    Peptides; 2019 Jan; 111():89-97. PubMed ID: 29684589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasorelaxation elicited by endogenous and exogenous hydrogen sulfide in mouse mesenteric arteries.
    Hart JL
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):551-564. PubMed ID: 31713651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
    Meurer S; Pioch S; Pabst T; Opitz N; Schmidt PM; Beckhaus T; Wagner K; Matt S; Gegenbauer K; Geschka S; Karas M; Stasch JP; Schmidt HH; Müller-Esterl W
    Circ Res; 2009 Jul; 105(1):33-41. PubMed ID: 19478201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiol-Based Redox Modulation of Soluble Guanylyl Cyclase, the Nitric Oxide Receptor.
    Beuve A
    Antioxid Redox Signal; 2017 Jan; 26(3):137-149. PubMed ID: 26906466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasorelaxant Effect of Novel Nitric Oxide-Hydrogen Sulfide Donor Chalcone in Isolated Rat Aorta: Involvement of cGMP Mediated sGC and Potassium Channel Activation.
    Sherikar A; Dhavale R; Bhatia M
    Curr Mol Pharmacol; 2020; 13(2):126-136. PubMed ID: 31654520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aging does not affect soluble guanylate cyclase redox state in mouse aortas.
    Shimosato T; Tawa M; Iwasaki H; Imamura T; Okamura T
    Physiol Rep; 2016 May; 4(10):. PubMed ID: 27233303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
    Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
    Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of mitochondrial superoxide decreasing ferrochelatase and heme in coronary artery soluble guanylate cyclase depletion by angiotensin II.
    Patel D; Alhawaj R; Kelly MR; Accarino JJ; Lakhkar A; Gupte SA; Sun D; Wolin MS
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1439-47. PubMed ID: 27037373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide.
    Fernhoff NB; Derbyshire ER; Underbakke ES; Marletta MA
    J Biol Chem; 2012 Dec; 287(51):43053-62. PubMed ID: 23093402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor.
    Montfort WR; Wales JA; Weichsel A
    Antioxid Redox Signal; 2017 Jan; 26(3):107-121. PubMed ID: 26979942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.
    Kollau A; Opelt M; Wölkart G; Gorren ACF; Russwurm M; Koesling D; Mayer B; Schrammel A
    Mol Pharmacol; 2018 Feb; 93(2):73-78. PubMed ID: 29138269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.
    Sayed N; Baskaran P; Ma X; van den Akker F; Beuve A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12312-7. PubMed ID: 17636120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.